SHIONOGI's Challenge in AI Innovation

SHIONOGI's AI Strategy - An Enterprise-Wide Initiative

Under the vision of HaaS (Healthcare as a Service), Shionogi & Co., Ltd. is committed to revolutionizing pharmaceutical development through the application of AI technology. AI utilization, which gained momentum in 2022, has been broadly deployed from improving existing operations to creating new value.

AI Application Case Study - Automation of Clinical Trial Programming

The "Artificial Intelligence Statistical Programming System" released in September 2023 enables AI to automatically generate statistical analysis programs (SAS) required for clinical trials, achieving a 30% reduction in standard work hours.

Generative AI-Powered Medical Writing Support in Pharmaceutical Development

In the pharmaceutical research and development process, documentation work during the clinical to early development stages represents a significant burden. The creation of specialized documents such as protocols and CSRs (Clinical Study Reports) requires substantial effort and impacts development timelines. By leveraging the template generation and style standardization capabilities of generative AI (Large Language Models), we aim to achieve efficiency improvements and quality enhancement in medical writing operations, thereby accelerating new drug development.

Challenge in Next-Generation AI Technology - Activities of the Generative AI Group

The Generative AI Group, established in October 2024, is advancing the development, implementation, and internal deployment of new operational support systems utilizing generative AI technology. Starting from field needs, we are accelerating business transformation by rapidly implementing "actually usable" and "secure" applications and continuously improving them.

1. Development of Business Support Applications

▶ Company-wide Base AI Applications

　－Ongoing enhancement of the enterprise AI chat application

　　(model updates, RAG functionality, API release, etc.)

▶Decision-Making Support AI

　－Executive Persona Application

　　(deepening project evaluation through dialogue from a management perspective)

　－Deliberation and Approval Support Application

　　(highlighting risks and key considerations prior to decision-making)

▶ AI for Medical Writing in Drug Development

　－Support for creating CSR (Clinical Study Reports)

　－Support for drafting clinical study protocols

▶ Cross-Department Document Search System

　－Internal document search across functions such as Clinical Development and CMC

　－Advanced intelligent document search capabilities

▶ Lightweight Application Suite

　 (using no-code LLM development tools)

　－Meeting minutes generation support

　－Guideline search support, etc.

2. Implementation and Integration of External Services

　－AI-powered literature search tools (SaaS)

　－Microsoft 365 Copilot, among others

3. Internal Education and Literacy Improvement

　－Information dissemination through the internal portal

　－Hands-on training tailored by level and theme

Future Outlook - The Future of Healthcare Pioneered by AI

These AI technologies are expected to become "fundamental technologies taken for granted" in the near future, supporting innovation across the entire healthcare industry. Shionogi continues its challenge toward realizing healthcare where AI creates value.